BCI
SRPT icon

Brinker Capital Investments’s Sarepta Therapeutics SRPT Stock Holding History

Brinker Capital Investments’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,385
Closed -$663K – 2047
2025
Q1 		$663K Buy
10,385
+2,358
+29% +$248K 0.01% 1277
2024
Q4 		$976K Sell
8,027
-1,731
-18% -$212K 0.01% 1070
2024
Q3 		$1.22M Sell
9,758
-177
-2% -$24.5K 0.01% 944
2024
Q2 		$1.57M Sell
9,935
-161
-2% -$20.7K 0.02% 765
2024
Q1 		$1.31M Buy
10,096
+3,123
+45% +$383K 0.01% 866
2023
Q4 		$716K Sell
6,973
-7,183
-51% -$689K 0.01% 1077
2023
Q3 		$1.72M Buy
14,156
+1,198
+9% +$135K 0.02% 683
2023
Q2 		$1.48M Buy
12,958
+8,687
+203% +$1.12M 0.02% 784
2023
Q1 		$589K Buy
4,271
+313
+8% +$40.6K 0.01% 1085
2022
Q4 		$513K Sell
3,958
-339
-8% -$39.3K 0.01% 969
2022
Q3 		$475K Buy
4,297
+150
+4% +$15.1K 0.01% 963
2022
Q2 		$311K Sell
4,147
-1,506
-27% -$111K 0.01% 1153
2022
Q1 		$442K Sell
5,653
-36
-0.6% -$2.76K 0.01% 1092
2021
Q4 		$512K Sell
5,689
-1,853
-25% -$158K 0.01% 1045
2021
Q3 		$586K Hold
7,542
– – 0.01% 929
2021
Q2 		$586K Buy
7,542
+2,301
+44% +$174K 0.01% 982
2021
Q1 		$391K Sell
5,241
-3,115
-37% -$287K 0.01% 969
2020
Q4 		$1.43M Buy
8,356
+3,854
+86% +$571K 0.02% 623
2020
Q3 		$632K Buy
+4,502
New +$684K 0.01% 834

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Brinker Capital Investments's SRPT Position: Q2 2025 in Review

Brinker Capital Investments sold out of Sarepta Therapeutics (SRPT) in Q2 2025, closing a stake of 10,385 shares — an estimated $663K sold.

Brinker Capital Investments first reported a position in SRPT in Q3 2020 and held it in 19 quarters. The position peaked at $1.72M in Q3 2023. 362 funds tracked by Wall St. Rank hold SRPT as of Q2 2025.

  • Brinker Capital Investments reported no remaining Sarepta Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Brinker Capital Investments sold 10,385 Sarepta Therapeutics shares in Q2 2025, an estimated $663K.
  • Brinker Capital Investments first reported a position in Sarepta Therapeutics in Q3 2020 and held it in 19 quarters.
  • Brinker Capital Investments's Sarepta Therapeutics position peaked at $1.72M in Q3 2023.
  • 362 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2025.

Based on Brinker Capital Investments's 13F filing for Q2 2025, filed 14 Aug 2025.